Low frequency spectral component of heart rate variability and myocardial beta-adrenoceptor density after acute

Stefano Guzzetti1, Nicos Spyrou, Stuart D Rosen

  • 1Università degli Studi Milano, Italy.

Insights

The blunted day-night pattern of the low frequency (LF) component of heart rate variability (HRV) in post-myocardial infarction (MI) patients indicates sustained sympathetic over-activity. This loss of oscillation is linked to reduced myocardial beta-adrenoceptor density.

Area of Science:

  • Cardiology
  • Autonomic Nervous System Research
  • Physiology

Background:

  • The low frequency (LF) spectral component of heart rate variability (HRV) typically reflects sympathetic nervous system activity.
  • In cardiovascular diseases, a blunted 24-hour pattern of the LF component is often observed.
  • The relationship between sympathetic drive and LF component patterns in non-physiological conditions requires further investigation.

Purpose of the Study:

  • To examine the association between chronic sympathetic efferent drive, indicated by myocardial beta-receptor density, and the 24-hour LF spectral component power in patients post-acute myocardial infarction (AMI).

Main Methods:

  • Heart rate variability (HRV) was analyzed over 24 hours in 24 post-AMI patients one month after uncomplicated Q wave MI.
  • Time domain measures (SDNN, SDANN) and spectral components (VLF, LF, HF) were calculated.
  • Myocardial beta-adrenoceptor density was quantified using in vivo positron emission tomography (PET) with 11-CGP-12177.

Main Results:

  • Post-AMI patients exhibited reduced myocardial beta-adrenoceptor density despite normal plasma catecholamine levels.
  • Patients showed lower SDNN and SDANN values compared to controls, with a blunted day-night oscillation in LF spectral component power.
  • A significant positive correlation was found between the day-night change in LF spectral component power and myocardial beta-adrenoceptor density (r = 0.51; p < 0.001).

Conclusions:

  • The diminished day-night oscillation of the LF spectral component is a significant indicator of sustained sympathetic over-activity in patients following AMI.
  • This finding highlights the potential of HRV analysis to assess autonomic dysfunction post-myocardial infarction.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Heart Failure Drugs: &#946;-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
Factors Influencing Heart Rate01:30

Factors Influencing Heart Rate

The heart rate, or pulse rate, is a vital indicator of cardiovascular health. It reflects the number of times the heart beats per minute. Various physiological and environmental factors influence heart rate, increasing or decreasing cardiac output. Understanding these factors is crucial for assessing heart function and identifying potential health issues.
Let us explore the significant factors affecting heart rate, including age, body temperature, posture, acute pain, chemical influences,...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...